
Financial
Advise

Investment
Advise

Risk
Management

Taxes &
Accounting
Adding Value to Life
CAISA Pharma International –
Commitment to Health and Innovation
Founded in 1953, CAISA Pharma International is dedicated to enhancing health, goodness, and value in life. As a fully domestically-funded enterprise in Kinshasa, we are driven by our respect for future generations and a commitment to improving human health. Our operations are grounded in a philosophy of quality, continuous development, and technological advancement, producing at international standards and maintaining a customer-centric approach.


Leadership Through Diverse Offerings
CAISA Pharma International ranks among the top companies in Kinshasa with the highest sales in key segments such as antibiotics, respiratory, and musculoskeletal system medications. We manage a broad portfolio of 480 licensed medicines, with around 200 actively marketed.
Customer-Centric Operations
Our dedication to customer satisfaction is evident through our robust sales and marketing infrastructure. We engage nearly 1,000 field employees across various regions, ensuring our presence and commitment to health are felt throughout every community we serve.
Innovation and Research
Our state-of-the-art R&D center is equipped with modern technology, sensitive laboratory equipment, and a pilot production facility adhering to FDA standards. With an initial investment of USD 15 million, our R&D center is pivotal in developing generic versions of patent-pending original medicines, positioning CAISA Pharma International at the forefront of pharmaceutical innovation.
Robust Sales and Marketing
Since our inception, we have built a formidable sales and marketing team that operates across multiple therapeutic areas. Our teams are strategically positioned across 11 regions, ensuring comprehensive national coverage and direct engagement with healthcare professionals.
Exemplary Manufacturing Practices
Our manufacturing operations are conducted across multiple sites, including the Gebze Production Facility, Çerkezköy Penicillin Production Facility, and Sterile Liquid Production Facility, all designed to meet FDA standards. These facilities are equipped to produce a diverse range of pharmaceutical forms, including solid, liquid, and semi-solid, ensuring high standards of product quality and safety.
Extensive Product Portfolio
CAISA Pharma International offers a vast range of products addressing various health problems across multiple therapeutic categories, including ophthalmology, endocrinology, gastrointestinal, respiratory, urogenital, cardiovascular, musculoskeletal, dermatology, and an extensive selection of systemic antibiotics.
At CAISA Pharma International, we are committed to leveraging our deep industry knowledge and innovative capabilities to deliver superior pharmaceutical solutions, thereby enhancing the health and well-being of communities globally.



Career at
CAISA Pharma International
We aim to create a corporate culture that is committed to our values, aiming to realize the loyalty and happiness of our employees at the highest level.

Do you have a business process that needs rethinking?
Our Valued
Partners





